The $800 Million Pill: The Truth behind the Cost of New Drugs by Goozner, Merrill

Used - Good. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages.

University of California Press, 2004. Hardcover. Like New. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.Dust jacket quality is not guaranteed.

University of California Press, 2004. Hardcover. Very Good. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.Dust jacket quality is not guaranteed.

University of California Press, 4/22/2004 12:00:01 A. hardcover. Good. 1.2000 in x 9.0000 in x 6.1000 in.

University of California Press, 2004-04-22. Hardcover. Good.

University of California Press. Used - Very Good. Very Good condition. Very Good dust jacket. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner’s name, short gifter’s inscription or light stamp. Bundled media such as CDs, DVDs, floppy disks or access codes may not be included.

Hardback. Very Good.

University of California Press, April 2004. Hardcover. USED Good.

Berkeley. 2004. University Of California Press. 1st American Edition. Very Good in Dustjacket. 0520239458. 297 pages. hardcover. keywords: Drugs Sociology . FROM THE PUBLISHER - Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposE, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line… Read More

University of California Press, 2004-03-19. Hardcover. Very Good. 3.0457 in x 22.8426 in x 15.4822 in.